Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Class A Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
424,966,351
-
Total 13F shares
-
317,255,108
-
Share change
-
-3,090,189
-
Total reported value
-
$9,879,343,045
-
Put/Call ratio
-
38%
-
Price per share
-
$31.13
-
Number of holders
-
444
-
Value change
-
-$34,196,805
-
Number of buys
-
236
-
Number of sells
-
197
Institutional Holders of Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) as of Q1 2025
As of 31 Mar 2025,
Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) was held by
444 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
317,255,108 shares.
The largest 10 holders included
MORGAN STANLEY, FMR LLC, VANGUARD GROUP INC, BlackRock, Inc., BAILLIE GIFFORD & CO, Swedbank AB, VIKING GLOBAL INVESTORS LP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
445
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.